Ronald Blue Trust, Inc. Alkermes Plc. Transaction History
Ronald Blue Trust, Inc.
- $8.16 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,821 shares of ALKS stock, worth $55,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,821
Previous 73
2394.52%
Holding current value
$55,012
Previous $2,000
2500.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
359Shares Held
180MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$879 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$573 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$393 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$382 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$277 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.96B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...